Orchestra BioMed Holdings, Inc. (OBIO) Free cash flow 2022–2025
Orchestra BioMed Holdings, Inc. (OBIO) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$49.5MFY2025 · since FY2022: -$29.9M → -$49.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$49.5M | +2.7% |
| FY2024 | -$50.8M | -10.0% |
| FY2023 | -$46.2M | -54.6% |
| FY2022 | -$29.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More OBIO financial trends
OBIO RevenueOBIO Net incomeOBIO Net marginOBIO Gross profitOBIO Gross marginOBIO Operating incomeOBIO Operating marginOBIO Operating cash flowOBIO Capital expendituresOBIO Return on equityOBIO Stock buybacksOBIO Dividends paidOBIO Total assetsOBIO Total liabilitiesOBIO Shareholders’ equityOBIO overview →